Ziprasidone Hcl
Rank #420 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$20.8M
Total Cost
239,041
Total Claims
$20.8M
Total Cost
8,071
Prescribers
$87
Cost per Claim
6,138
Beneficiaries
289,214
30-Day Fills
$2,578
Avg Cost/Provider
30
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$20.8M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $20.8M total
Top Prescribers of Ziprasidone Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Timothy Cullinane | Psychiatry | Elmhurst, IL | 18 | $74K |
| 2 | Sarah Wood | Physician Assistant | Ontario, OR | 14 | $63K |
| 3 | Ramon Garcia | Psychiatry | Sacramento, CA | 462 | $45K |
| 4 | Veda Vyas | Psychiatry | Winter Park, FL | 279 | $41K |
| 5 | Michael Lisiak | Neuropsychiatry | Atascadero, CA | 145 | $38K |
| 6 | Robert Morton | Psychiatry | Ada, OK | 297 | $38K |
| 7 | Daniel Binus | Psychiatry | Auburn, CA | 11 | $37K |
| 8 | Donna Piccininni | Nurse Practitioner | Saco, ME | 23 | $36K |
| 9 | Elaine Walker | Physician Assistant | Butner, NC | 20 | $36K |
| 10 | Kim Holland | Nurse Practitioner | Duncan, OK | 12 | $35K |
| 11 | Christine Musgrove | Nurse Practitioner | Kansas City, KS | 118 | $35K |
| 12 | Hoover Royals | Family Practice | Dover, NC | 160 | $34K |
| 13 | Juliana Kanji | Psychiatry | Huntington, NY | 23 | $32K |
| 14 | Janet Scholle | Psychiatry | Wpb, FL | 24 | $32K |
| 15 | Steven Macina | Psychiatry | Huntington Beach, CA | 235 | $32K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 417 | Methenamine Hippurate (Methenamine Hippurate) | $21.0M | 246,988 |
| 418 | Daratumumab-Hyaluronidase-Fihj (Darzalex Faspro) | $21.0M | 1,444 |
| 419 | Insulin Pump Cart,cont Inf,bt (Omnipod Dash Pods (Gen 4)) | $20.9M | 16,219 |
| 420 | Ziprasidone Hcl (Ziprasidone Hcl) | $20.8M | 239,041 |
| 421 | Sodium, Potassium,mag Sulfates (Sod Sulf-Potass Sulf-Mag Sulf) | $20.7M | 246,742 |
| 422 | Efinaconazole (Jublia) | $20.4M | 15,425 |
| 423 | Mometasone/Formoterol (Dulera) | $20.4M | 46,961 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology